首页|期刊导航|中国实用神经疾病杂志|脑脊液突触体相关蛋白25在阿尔茨海默病中的作用及其与相关认知域的关系

脑脊液突触体相关蛋白25在阿尔茨海默病中的作用及其与相关认知域的关系OA

Role of cerebrospinal fluid synaptosomal-associated protein 25 in Alzheimer's disease and its relationship with cognitive domains

中文摘要英文摘要

目的 通过横断面及纵向观察研究脑脊液突触体相关蛋白25(SNAP-25)在AD诊断及预测痴呆进展中的作用及其与相关认知域的关联性.方法 将阿尔茨海默病神经影像学倡议计划(ADNI)数据库中146例测量了脑脊液中SNAP-25的受试者根据认知状态分为正常组(n=55)、MCI组(n=75)和痴呆组(n=16).在后续的纵向研究中,依据5a内是否进展为痴呆将75例MCI患者分为稳定型MCI(sMCI)42例和进展型MCI(pMCI)33例.采用非参数检验比较脑脊液SNAP-25水平的组间差异.采用受试者工作特征(ROC)曲线评估脑脊液SNAP-25诊断AD及预测痴呆进展的价值.采用Kaplan-Meier生存曲线分析脑脊液SNAP-25预测MCI向痴呆进展的风险.以脑脊液SNAP-25预测MCI向痴呆转化的ROC曲线的最佳界值为截断值,将研究人群分为低水平组(n=77)和高水平组(n=69),采用非参数检验比较高低水平组间MMSE评分、ADAS-Cog评分、RAVLT评分、TMT-B评分.采用Spearman相关分析对基线脑脊液SNAP-25水平与基线MMSE评分、ADAS-Cog评分、RAVLT评分、TMT-B评分及上述量表每年评分的变化率(△MMSE、△ ADAS、△RAVLT、△TMT-B)进行相关性分析.结果 痴呆组和MCI组脑脊液SNAP-25水平显著高于正常组,有统计学差异(P=0.032、0.005).ROC曲线分析显示,脑脊液SNAP-25水平对于区别痴呆组与正常组的AUC为0.77(P=0.001,95%CI:0.65~0.90),且与AD的脑脊液核心标记物的诊断效能相当.此外,对MCI组进一步随访分析显示pMCI组的脑脊液SNAP-25水平显著高于sMCI组,差异具有统计学意义(P=0.015).ROC曲线分析显示,脑脊液SNAP-25预测MCI向痴呆进展的AUC为0.66(P=0.019,95%CI:0.53~0.78).Kaplan-Meier 生存分析显示,脑脊液 SNAP-25 水平高的 MCI 人群进展为痴呆的风险是脑脊液SNAP-25水平低的MCI人群的2.89倍(P=0.015,95%CI:1.38~6.03).进一步针对不同脑脊液SNAP-25水平组的分析显示,高水平组的基线MMSE评分显著低于低水平组,基线ADAS-Cog评分显著高于低水平组,差异均有统计学意义(P=0.007、0.013),2组在基线RAVLT评分和基线TMT-B评分上差异无统计学意义(P>0.05).高水平组每年MMSE评分的下降及每年RAVLT评分的下降显著高于低水平组,差异均有统计学意义(P<0.001,P=0.005),高水平组每年ADAS-Cog评分的增高及每年TMT-B评分的增高显著高于低水平组,差异有统计学意义(P=0.027、0.002).Spearman相关分析显示,基线脑脊液SNAP-25浓度与基线MMSE评分(rs=-0.27,P=0.001,n=146)和基线RAVLT评分(rs=-0.25,P=0.003,n=146)呈负相关,与基线ADAS-Cog评分(rs=0.26,P=0.002,n=146)呈正相关,与基线TMT-B评分(rs=0.05,P=0.511,n=145)无相关性.基线脑脊液SNAP-25浓度与△MMSE(rs=-0.29,P=0.001,n=119)、△ADAS(rs=-0.27,P=0.009,n=122)、△RAVLT(rs=-0.22,P=0.017,n=119)均呈负相关,与△TMT-B(rs=0.28,P=0.002,n=119)呈正相关.结论 脑脊液SNAP-25水平能够反映AD认知状态的严重程度,与MCI向痴呆进展的风险有关.此外,脑脊液SNAP-25水平与整体认知功能、记忆功能、执行功能的损伤程度相关.

Objective To investigate the role of cerebrospinal fluid(CSF)synaptosomal associated protein 25(SNAP-25)in the diagnosis and prediction of dementia progression and its association with the relevant cognitive domains by cross-sectional and longitudinal observations.Methods A total of 146 participants with CSF SNAP-25 data from Alzheimer's Disease Neuroimaging Initiative(ADNI)database included 55 cognitively unimpaired(CU)subjects,75 mild cognitive impairment(MCI)subjects,and 16 subjects with dementia.Among 75 MCI individuals with at least 6 months of follow-up clinical assessments,we found 42 remained stable(stable MCI,sMCI),whereas 33 progressed to dementia(progressive MCI,pMCI).Non-parametric tests were used to compare the inter-group differences in CSF SNAP-25 levels.The value of CSF SNAP-25 in diagnosing AD and predicting dementia progression was evaluated by receiver operating characteristics(ROC)curve.Kaplan-Meier survival curve was used to analyze the value of CSF SNAP-25 in predicting the risk of MCI progression to dementia.Finally,the optimal cut-off value of ROC curve for predicting the transformation of MCI to dementia with CSF SNAP-25 was the cut-off value,and the study population was divided into low level group(n=77)and high level group(n=69).Non-parametric test was used to compare the differences of MMSE score,ADAS-Cog score,RAVLT score and MTT-B score between the high level group and the low level group.Spearman correlation analysis was used to analyze the correlation between baseline CSF SNAP-25 level and baseline MMSE score,ADAS-cog score,RAVLT score,TMT-B score and the annual rate of change(△MMSE,△ ADAS,△RAVLT,△TMT-B).Results The CSF SNAP-25 levels was higher in dementia individuals and MCI individuals compared with CU controls(P=0.032,0.005).In addition,further follow-up analysis of the MCI group showed that the level of CSF SNAP-25 in pMCI group was significantly higher than that in sMCI group(P=0.015).ROC curve analysis showed that the AUC of CSF SNAP-25 predicting MCI progression to dementia was 0.66(P=0.019,95%CI:0.53-0.78).Kaplan-Meier survival analysis showed that the risk of progression to dementia in MCI subjects with high CSF SNAP-25 levels was 2.89 times greater than in MCI subjects with low CSF SNAP-25 levels(P=0.015,95%CI:1.38-6.03).Further analysis of different CSF SNAP-25 level groups showed that the baseline MMSE score of high level group was significantly lower than that of low level group(P=0.007),the baseline ADAS-Cog score of high level group was significantly higher than that of low level group(P=0.013),while there was no significant difference in baseline RAVLT score and baseline MTT-B score between the two groups(P>0.05).The decrease of annual MMSE score and annual RAVLT score of high level group was significantly higher than that of low level group(P<0.001,P=0.005),the increase of annual ADAS-Cog score and annual MTT-B score of high level group was significantly higher than that of low level group(P=0.027,0.002).Spearman correlation analysis showed that the baseline CSF SNAP-25 level was negatively correlated with the baseline MMSE score(rs=-0.27,P=0.001,n=146)and the baseline RAVLT score(rs=-0.25,P=0.003,n=146),positively correlated with the baseline ADAS-Cog score(rs=0.26,P=0.002,n=146),and not correlated with the baseline TMT-B score(rs=0.05,P=0.511,n=145).The baseline cerebrospinal fluid SNAP-25 concentration was negatively correlated with △MMSE(rs=-0.29,P=0.001,n=119),△ADAS(rs=-0.27,P=0.009,n=122),and △RAVLT(rs=-0.22,P=0.017,n=119),and positively correlated with △ TMT-B(rs=0.28,P=0.002,n=119).Conclusion CSF SNAP-25 levels increase with disease severity and are associated with the risk of MCI progression to dementia.In addition,the level of CSF SNAP-25 was correlated with the degree of impairment of overall cognitive function,memory function and executive function.

艾伟平;向春晨;王淑荣;张玉梅

首都医科大学附属北京天坛医院,北京 100070||张家口市第一医院,河北 张家口 075000首都医科大学附属北京天坛医院,北京 100070海南医学院第一附属医院,海南 海口 570102首都医科大学附属北京天坛医院,北京 100070

医药卫生

阿尔茨海默病突触体相关蛋白25脑脊液生物标志物轻度认知障碍

Alzheimer's diseaseSynaptosomal-associated protein 25Cerebrospinal fluidBiomarkerMild cognitive impairment

《中国实用神经疾病杂志》 2026 (2)

147-154,8

国家自然科学基金资助项目(编号:82372555)

10.12083/SYSJ.251299

评论